1. Home
  2. ZKH vs ALLO Comparison

ZKH vs ALLO Comparison

Compare ZKH & ALLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZKH
  • ALLO
  • Stock Information
  • Founded
  • ZKH 1998
  • ALLO 2017
  • Country
  • ZKH China
  • ALLO United States
  • Employees
  • ZKH N/A
  • ALLO N/A
  • Industry
  • ZKH
  • ALLO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ZKH
  • ALLO Health Care
  • Exchange
  • ZKH Nasdaq
  • ALLO Nasdaq
  • Market Cap
  • ZKH 616.9M
  • ALLO 677.5M
  • IPO Year
  • ZKH 2023
  • ALLO 2018
  • Fundamental
  • Price
  • ZKH $3.83
  • ALLO $2.27
  • Analyst Decision
  • ZKH Strong Buy
  • ALLO Buy
  • Analyst Count
  • ZKH 2
  • ALLO 12
  • Target Price
  • ZKH $12.65
  • ALLO $10.06
  • AVG Volume (30 Days)
  • ZKH 67.7K
  • ALLO 2.6M
  • Earning Date
  • ZKH 11-22-2024
  • ALLO 11-07-2024
  • Dividend Yield
  • ZKH N/A
  • ALLO N/A
  • EPS Growth
  • ZKH N/A
  • ALLO N/A
  • EPS
  • ZKH N/A
  • ALLO N/A
  • Revenue
  • ZKH $1,213,635,386.00
  • ALLO $43,000.00
  • Revenue This Year
  • ZKH $4.02
  • ALLO N/A
  • Revenue Next Year
  • ZKH $16.24
  • ALLO $5,902.96
  • P/E Ratio
  • ZKH N/A
  • ALLO N/A
  • Revenue Growth
  • ZKH 2.49
  • ALLO 26.47
  • 52 Week Low
  • ZKH $2.62
  • ALLO $2.01
  • 52 Week High
  • ZKH $21.91
  • ALLO $5.78
  • Technical
  • Relative Strength Index (RSI)
  • ZKH 54.01
  • ALLO 36.00
  • Support Level
  • ZKH $3.75
  • ALLO $2.95
  • Resistance Level
  • ZKH $4.03
  • ALLO $3.36
  • Average True Range (ATR)
  • ZKH 0.23
  • ALLO 0.26
  • MACD
  • ZKH -0.01
  • ALLO -0.06
  • Stochastic Oscillator
  • ZKH 50.51
  • ALLO 0.91

About ZKH ZKH Group Limited each representing thirty-five (35)

ZKH Group Ltd engages in providing MRO procurement service platform in China. It provides one-stop MRO procurement and management services for its customers, and offers digital and fulfillment solutions for participants along the industry value chain. It offers a broad range of MRO product offerings covering all MRO product lines on its platform, including spare parts, chemicals, manufacturing parts, general consumables, and office supplies. All of the Group's revenues are derived from the PRC.

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, primarily generated from collaborations and licensing agreements, supports their research and development efforts.

Share on Social Networks: